Read More 1 minute read Analyst Ratings News Price Target Upgrades B of A Securities Upgrades Prothena Corp to Neutral, Announces $49 Price Target By Benzinga Newsdesk Today, 11:26 PM B of A Securities upgrades Prothena Corp (NASDAQ:PRTA) from Underperform to Neutral and announces $49 price target. PRTA
Read More 1 minute read Analyst Ratings News Price Target Upgrades Wells Fargo Upgrades Saia to Overweight, Announces $257 Price Target By Benzinga Newsdesk Today, 11:26 PM Wells Fargo analyst Allison Poliniak Cusic upgrades Saia (NASDAQ:SAIA) from Equal-Weight to Overweight and announces $257 price target. SAIA
Read More 1 minute read Analyst Ratings News Upgrades Wolfe Research Upgrades Alaska Air Gr to Outperform By Benzinga Newsdesk Today, 11:26 PM Wolfe Research analyst Hunter Keay upgrades Alaska Air Gr (NYSE:ALK) from Peer Perform to Outperform. ALK
Read More 1 minute read Analyst Ratings News Upgrades Wolfe Research Upgrades Delta Air Lines to Outperform By Benzinga Newsdesk Today, 11:26 PM Wolfe Research analyst Hunter Keay upgrades Delta Air Lines (NYSE:DAL) from Underperform to Outperform. DAL
Read More 1 minute read Analyst Ratings News Price Target Upgrades Morgan Stanley Upgrades Marathon Oil to Equal-Weight, Raises Price Target to $15 By Benzinga Newsdesk Today, 11:26 PM Morgan Stanley analyst Devin McDermott upgrades Marathon Oil (NYSE:MRO) from Underweight to Equal-Weight and raises the price target from $12 to $15. MRO
Read More 1 minute read Analyst Ratings News Price Target Upgrades Morgan Stanley Upgrades Occidental Petroleum to Overweight, Raises Price Target to $40 By Benzinga Newsdesk Today, 11:26 PM Morgan Stanley analyst Devin McDermott upgrades Occidental Petroleum (NYSE:OXY) from Equal-Weight to Overweight and raises the price target from $32 to $40. OXY
Read More 1 minute read Analyst Ratings News Price Target Upgrades Piper Sandler Upgrades Biogen to Overweight, Raises Price Target to $450 By Benzinga Newsdesk Today, 11:26 PM Piper Sandler analyst Christopher Raymond upgrades Biogen (NASDAQ:BIIB) from Neutral to Overweight and raises the price target from $384 to $450. BIIB
Read More 1 minute read Analyst Ratings News Price Target Upgrades BMO Capital Upgrades National Health Investors to Market Perform, Announces $71 Price Target By Benzinga Newsdesk Today, 11:26 PM BMO Capital analyst John Kim upgrades National Health Investors (NYSE:NHI) from Underperform to Market Perform and announces $71 price target. NHI
Read More 1 minute read Analyst Ratings News Price Target Upgrades JP Morgan Upgrades Lennar to Overweight, Announces $141 Price Target By Benzinga Newsdesk Today, 11:26 PM JP Morgan analyst Michael Rehaut upgrades Lennar (NYSE:LEN) from Neutral to Overweight and announces $141 price target. LEN
Read More 1 minute read Analyst Ratings News Price Target Upgrades JP Morgan Upgrades Crinetics Pharmaceuticals to Overweight, Announces $28 Price Target By Benzinga Newsdesk Today, 11:26 PM JP Morgan analyst Jessica Fye upgrades Crinetics Pharmaceuticals (NASDAQ:CRNX) from Neutral to Overweight and announces $28 price target. CRNX